Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-15

Clinical Trial Update: Filgotinib Alone and in Combination With Methotrexate (MTX) in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Are Naive to MTX Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial update on filgotinib alone and with methotrexate in adults with moderately to severely active rheumatoid arthritis who are MTX-naive; trial comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Filgotinib (filgotinib)
  • METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Gilead Sciences | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2021-01-15